Has AI Reshaped Drug Discovery, or Is There Still a Long Way to Go?
{{output}}
The conventional drug discovery pipeline is labour-intensive, time-consuming, and costly, involving target identification, hit discovery, lead optimization, and extensive preclinical and clinical evaluation. To overcome these limitations, artificial intelligen... ...
